tiprankstipranks
Trending News
More News >
Addex Therapeutics Ltd (ADR) (ADXN)
:ADXN
US Market
Advertisement

Addex Therapeutics (ADXN) Income Statement

Compare
73 Followers

Addex Therapeutics Income Statement

Last quarter (Q1 2025), Addex Therapeutics's total revenue was CHF0.00, a decrease of -100.00% from the same quarter last year. In Q1, Addex Therapeutics's net income was CHF-1.47M. See Addex Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
CHF 404.10KCHF 1.61MCHF 1.42MCHF 2.92MCHF 3.61M
Gross Profit
CHF -444.26KCHF -5.32MCHF -13.20MCHF -9.90MCHF -6.76M
Operating Expenses
CHF 2.31MCHF 4.99MCHF 21.94MCHF 18.42MCHF 15.86M
Depreciation and Amortization
CHF 260.12KCHF 305.95KCHF 323.14KCHF 347.61KCHF 378.75K
EBITDA
CHF -4.65MCHF -10.23MCHF -20.23MCHF -14.94MCHF -12.41M
Operating Income
CHF -2.76MCHF -10.28MCHF -20.52MCHF -15.51MCHF -12.24M
Other Income/Expenses
CHF -2.15MCHF -274.93KCHF -284.01KCHF 154.00KCHF -615.33K
Pretax Income
CHF -4.91MCHF -10.56MCHF -20.80MCHF -15.35MCHF -12.86M
Net Income
CHF 7.06MCHF -10.56MCHF -20.80MCHF -15.35MCHF -12.86M
Per Share Metrics
Basic EPS
CHF 8.40CHF -16.80CHF -55.20CHF -54.00CHF -57.60
Diluted EPS
CHF 8.40CHF -16.80CHF -55.20CHF -54.00CHF -57.60
Weighted Average Shares Outstanding
817.61K 619.23K 376.54K 284.33K 222.35K
Weighted Average Shares Outstanding (Diluted)
817.61K 619.23K 376.54K 284.33K 222.35K
Currency in CHF

Addex Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis